Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 3/20 | 0.40 |
| ▸ | DRD4 | P21917 | 3/20 | 0.40 |
| ▸ | DRD3 | P35462 | 3/20 | 0.40 |
| ▸ | GSK3B | P49841 | 2/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3839084 | 0.83 | TDP1 (0.52) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL256865 | 0.82 | CA12 (0.52) | TSHRCA12CA1CA2CA9 | |
| SCHEMBL103415 | 0.82 | ALDH1A1 (0.47) | ALDH1A1TSHRCA12CA1CA2 | |
| SCHEMBL29411053 | 0.82 | CA12 (0.52) | TSHRCA12CA1CA2CA9 | |
| Hydrochloric Acid SCHEMBL4350304 | 0.80 | CA12 (0.50) | TSHRCA12CA1CA2CA9 | |
| SCHEMBL1568517 | 0.80 | PARP1 (0.53) | TSHRCA12CA1CA2CA9 | |
| SCHEMBL31575813 | 0.80 | GSK3B (0.61) | ALDH1A1TSHRMEN1KMT2AGSK3B | |
| SCHEMBL10412423 | 0.80 | ALDH1A1 (0.46) | ALDH1A1TSHRMEN1KMT2ATDP1 | |
| SCHEMBL1636079 | 0.80 | LMNA (0.47) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL19881259 | 0.80 | CA12 (0.43) | CA12CA1CA2CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250257041-A1 | INDUCERS OF INTEGRATED STRESS RESPONSE TO TREAT CANCER | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2025-08-14 | — | — | US | disclosed |
| EP-4526291-A1 | INDUCERS OF INTEGRATED STRESS RESPONSE TO TREAT CANCER | The Board of Regents of the University of Texas System (US) | 2025-03-26 | — | — | EP | disclosed |
| WO-2023225327-A1 | INDUCERS OF INTEGRATED STRESS RESPONSE TO TREAT CANCER | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-11-23 | — | — | WO | disclosed |
| US-11407745-B2 | Indazole derivatives and pharmaceutical composition for preventing, alleviating or treating cancer containing the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2022-08-09 | — | — | US | disclosed |
| US-20200392127-A1 | NOVEL INDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING CANCER CONTAINING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2020-12-17 | — | — | US | disclosed |
| US-20150243910-A1 | TRANSITION METAL COMPLEXES COMPRISING ASYMMETRIC TETRADENTATE LIGANDS | SOLVAY (BE) | 2015-08-27 | — | — | US | disclosed |
| US-20150243910-A1 | TRANSITION METAL COMPLEXES COMPRISING ASYMMETRIC TETRADENTATE LIGANDS | SOLVAY (BE) | 2015-08-27 | — | — | US | disclosed |
| WO-2014033050-A1 | TRANSITION METAL COMPLEXES COMPRISING ASYMMETRIC TETRADENTATE LIGANDS | SOLVAY SA (BE) | 2014-03-06 | — | — | WO | disclosed |
| EP-2042506-B1 | SUBSTITUTED PHENYLETHYNYL GOLD-NITROGENATED HETEROCYCLIC CARBENE COMPLEX | UBE INDUSTRIES (JP) | 2012-12-19 | — | — | EP | disclosed |
| US-7932398-B2 | Substituted phenylethynylgold-nitrogen-containing heterocyclic carbene complex | UBE INDUSTRIES, LTD. (JP) | 2011-04-26 | — | — | US | disclosed |
| US-20090234130-A1 | SUBSTITUTED PHENYLETHYNYLGOLD-NITROGEN-CONTAINING HETEROCYCLIC CARBENE COMPLEX | UBE INDUSTRIES, LTD. (JP) | 2009-09-17 | — | — | US | disclosed |
| US-20090221779-A1 | FILM FORMING COMPOSITION, INSULATING FILM, AND ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2009-09-03 | — | — | US | disclosed |
| US-20090221779-A1 | FILM FORMING COMPOSITION, INSULATING FILM, AND ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2009-09-03 | — | — | US | disclosed |
| EP-1457511-B1 | CROSSLINKABLE AROMATIC RESINS HAVING PROTONIC ACID GROUPS AND ION CONDUCTIVE POLYMER MEMBRANES BINDERS AND FUEL CELLS MADE BY USING THE SAME | MITSUI CHEMICALS INC (JP) | 2009-07-15 | — | — | EP | disclosed |
| EP-2042506-A1 | SUBSTITUTED PHENYLETHYNYL GOLD-NITROGENATED HETEROCYCLIC CARBENE COMPLEX | Ube Industries, Ltd. (JP) | 2009-04-01 | — | — | EP | disclosed |
| US-7345135-B2 | Crosslinkable aromatic resin having protonic acid group, and ion conductive polymer membrane, binder and fuel cell using the resin | MITSUI CHEMICALS, INC. (JP) | 2008-03-18 | — | — | US | disclosed |
| US-20040191602-A1 | Crosslinkable aromatic resin having protonic acid group, and ion conductive polymer membrane, binder and fuel cell using the resin | MITSUI CHEMICALS, INC. (JP) | 2004-09-30 | — | — | US | disclosed |
| EP-1457511-A1 | CROSSLINKABLE AROMATIC RESINS HAVING PROTONIC ACID GROUPS AND ION CONDUCTIVE POLYMER MEMBRANES BINDERS AND FUEL CELLS MADE BY USING THE SAME | Mitsui Chemicals, Inc. (JP) | 2004-09-15 | — | — | EP | disclosed |
| US-4837256-A | SOLVENT RESISTANCE | AMOCO CORPORATION (US) | 1989-06-06 | — | — | US | disclosed |
| US-4739089-A | Acylation of polysilylaromatic organic compounds and products obtained therefrom | GENERAL ELECTRIC COMPANY (US) | 1988-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200392127-A1 | NOVEL INDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING CANCER CONTAINING THE SAME | ABL1, DDR1, ABL2 | ALDH1A1 1095/4885TSHR 3988/4885CA12 4865/4885 |
| US-20250257041-A1 | INDUCERS OF INTEGRATED STRESS RESPONSE TO TREAT CANCER | DDIT3, ATF4, EIF2AK3 | ALDH1A1 4205/4885TSHR 4131/4885CA12 4559/4885 |
| US-11407745-B2 | Indazole derivatives and pharmaceutical composition for preventing, alleviating or treating cancer containing the same | ABL1, DDR1, ABL2 | ALDH1A1 1028/4885TSHR 3712/4885CA12 4873/4885 |
| US-20090234130-A1 | SUBSTITUTED PHENYLETHYNYLGOLD-NITROGEN-CONTAINING HETEROCYCLIC CARBENE COMPLEX | CCRL2, CCNL2, ATXN2L | ALDH1A1 3101/4885TSHR 3248/4885CA12 924/4885 |
| US-20090221779-A1 | FILM FORMING COMPOSITION, INSULATING FILM, AND ELECTRONIC DEVICE | CCNT1, CCNA1, BMI1 | ALDH1A1 1449/4885TSHR 3841/4885CA12 263/4885 |
| US-20150243910-A1 | TRANSITION METAL COMPLEXES COMPRISING ASYMMETRIC TETRADENTATE LIGANDS | AP2M1, AP3M1, AP1M1 | ALDH1A1 3225/4885TSHR 2338/4885CA12 827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.